These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 17567728)
1. Cholesterol-lowering effect of ezetimibe in uridine diphosphate glucuronosyltransferase 1A-deficient (Gunn) rats. Yamamoto T; Ito K; Honma M; Takada T; Suzuki H Drug Metab Dispos; 2007 Sep; 35(9):1455-8. PubMed ID: 17567728 [TBL] [Abstract][Full Text] [Related]
2. Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities. Wang SW; Kulkarni KH; Tang L; Wang JR; Yin T; Daidoji T; Yokota H; Hu M J Pharmacol Exp Ther; 2009 Jun; 329(3):1023-31. PubMed ID: 19264971 [TBL] [Abstract][Full Text] [Related]
3. In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs. Hawes BE; O'neill KA; Yao X; Crona JH; Davis HR; Graziano MP; Altmann SW Mol Pharmacol; 2007 Jan; 71(1):19-29. PubMed ID: 17005902 [TBL] [Abstract][Full Text] [Related]
4. Glucuronidation converting methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a potent apical sodium-dependent bile acid transporter inhibitor, resulting in a hypocholesterolemic action. Sakamoto S; Kusuhara H; Miyata K; Shimaoka H; Kanazu T; Matsuo Y; Nomura K; Okamura N; Hara S; Horie K; Baba T; Sugiyama Y J Pharmacol Exp Ther; 2007 Aug; 322(2):610-8. PubMed ID: 17470645 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase. Hu Z; Wells PG J Pharmacol Exp Ther; 1992 Oct; 263(1):334-42. PubMed ID: 1403794 [TBL] [Abstract][Full Text] [Related]
11. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Ge L; Wang J; Qi W; Miao HH; Cao J; Qu YX; Li BL; Song BL Cell Metab; 2008 Jun; 7(6):508-19. PubMed ID: 18522832 [TBL] [Abstract][Full Text] [Related]
12. Identification of the UDP-glucuronosyltransferase responsible for bucolome N-glucuronide formation in rats. Kanoh H; Okada K; Mohri K Pharmazie; 2010 Nov; 65(11):840-4. PubMed ID: 21155392 [TBL] [Abstract][Full Text] [Related]
13. Extracellular loop C of NPC1L1 is important for binding to ezetimibe. Weinglass AB; Kohler M; Schulte U; Liu J; Nketiah EO; Thomas A; Schmalhofer W; Williams B; Bildl W; McMasters DR; Dai K; Beers L; McCann ME; Kaczorowski GJ; Garcia ML Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11140-5. PubMed ID: 18682566 [TBL] [Abstract][Full Text] [Related]
15. Defective induction of phenol glucuronidation by 3-methylcholanthrene in Gunn rats is due to the absence of a specific UDP-glucuronosyltransferase isoenzyme. Coughtrie MW; Burchell B; Shepherd IM; Bend JR Mol Pharmacol; 1987 Jun; 31(6):585-91. PubMed ID: 3110589 [TBL] [Abstract][Full Text] [Related]
16. Disposition and sterol-lowering effect of ezetimibe in multidrug resistance-associated protein 2-deficient rats. Oswald S; Westrup S; Grube M; Kroemer HK; Weitschies W; Siegmund W J Pharmacol Exp Ther; 2006 Sep; 318(3):1293-9. PubMed ID: 16772539 [TBL] [Abstract][Full Text] [Related]
17. NPC1L1-dependent transport of 27-alkyne cholesterol in intestinal epithelial cells. Ticho AL; Calzadilla N; Malhotra P; Lee H; Anbazhagan AN; Saksena S; Dudeja PK; Lee D; Gill RK; Alrefai WA Am J Physiol Cell Physiol; 2021 May; 320(5):C916-C925. PubMed ID: 33760662 [TBL] [Abstract][Full Text] [Related]
18. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. Davis HR; Veltri EP J Atheroscler Thromb; 2007 Jun; 14(3):99-108. PubMed ID: 17587760 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated gene therapy to restore expression and functionality of multiple UDP-glucuronosyltransferase 1A enzymes in Gunn rat liver. Miles KK; Kessler FK; Webb LJ; Smith PC; Ritter JK J Pharmacol Exp Ther; 2006 Sep; 318(3):1240-7. PubMed ID: 16763095 [TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of ezetimibe. Simard C; Turgeon J Can J Clin Pharmacol; 2003; 10 Suppl A():13A-20A. PubMed ID: 14571304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]